2022
DOI: 10.1097/mjt.0000000000001577
|View full text |Cite
|
Sign up to set email alerts
|

Ivermectin for COVID-19: The 2022 Update

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…The recommendation was strongly refuted by independent commentators 8 and rejected in 2022 by the US National Institutes of Health 9 and the US Centers for Disease Control and Prevention. 10 Well-designed, appropriately blinded, randomized controlled trials performed in the United States 11,12 and elsewhere 13 indicated no beneficial effect for ivermectin. Once the ivermectin was used in the United States, the number of calls to Poison Control Centers may have increased; in Oregon in the month of August, 2021, there were 21 such calls, 6 patients required admission to the hospital, and 4 of them received care in an intensive care unit for ataxia or hypotension, but a causal relationship was difficult to ascertain as the mechanism is not known.…”
mentioning
confidence: 99%
“…The recommendation was strongly refuted by independent commentators 8 and rejected in 2022 by the US National Institutes of Health 9 and the US Centers for Disease Control and Prevention. 10 Well-designed, appropriately blinded, randomized controlled trials performed in the United States 11,12 and elsewhere 13 indicated no beneficial effect for ivermectin. Once the ivermectin was used in the United States, the number of calls to Poison Control Centers may have increased; in Oregon in the month of August, 2021, there were 21 such calls, 6 patients required admission to the hospital, and 4 of them received care in an intensive care unit for ataxia or hypotension, but a causal relationship was difficult to ascertain as the mechanism is not known.…”
mentioning
confidence: 99%